Díaz, C., & Zapata, C. (2022). Profound molecular response with ponatinib in chronic phase of chronic myeloid leukemia with resistance to imatinib and dasatinib: Case report and review of the literature. Revista Médica Herediana, 33(2), 133–138. https://doi.org/10.20453/rmh.v33i2.4247